• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素 V1B 受体的亚细胞定位和内化。

Subcellular localization and internalization of the vasopressin V1B receptor.

机构信息

Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan.

Department of Functional Genomics, Graduate School of Pharmaceutical Sciences, Himeji Dokkyo University, Hyogo 670-8524, Japan.

出版信息

Eur J Pharmacol. 2015 Oct 15;765:291-9. doi: 10.1016/j.ejphar.2015.08.043. Epub 2015 Aug 28.

DOI:10.1016/j.ejphar.2015.08.043
PMID:26318147
Abstract

Only limited information is available on agonist-dependent changes in the subcellular localization of vasopressin V1B receptors. Our radioligand binding study of membrane preparations and intact cells revealed that a large fraction of the V1B receptor is located in the cytoplasm in unstimulated CHO cells, which is in contrast to the plasma membrane localization of the V1A and V2 receptors. Moreover, when the affinity of radiolabeled arginine-vasopressin ([3H]AVP) was compared between membrane preparations and intact cells, the affinity of [3H]AVP to the cell surface V1B receptors, but not the V1A receptors, was significantly reduced. Although the number and affinity of cell surface V1B receptors decreased, they became extensively internalized upon binding with [3H]AVP. Approximately 87% of cell surface-bound [3H]AVP was internalized and became resistant to acid wash during incubation with 1 nM [3H]AVP. By contrast, less ligand (35%) was internalized in the cells expressing the V1A receptor. Extensive internalization of the V1B receptors was partially attenuated by inhibitors of cytoskeletal proteins, siRNA against β-arrestin 2, or the removal of sodium chloride from the extracellular buffer, indicating that this internalization involves clathrin-coated pits. Together, these results indicate that the mechanism that regulates the number and affinity of V1B receptors in the plasma membrane is markedly distinct from the corresponding mechanisms for the V1A and V2 receptors and plays a critical role under stress conditions, when vasopressin release is augmented.

摘要

仅有有限的信息可用于研究血管加压素 V1B 受体的激动剂依赖性的亚细胞定位变化。我们对膜制剂和完整细胞的放射性配体结合研究表明,在未受刺激的 CHO 细胞中,大量 V1B 受体位于细胞质中,这与 V1A 和 V2 受体的质膜定位形成对比。此外,当比较膜制剂和完整细胞之间放射性标记的精氨酸血管加压素 ([3H]AVP) 的亲和力时,[3H]AVP 与细胞表面 V1B 受体的亲和力(而非 V1A 受体)显著降低。尽管细胞表面 V1B 受体的数量和亲和力降低,但它们在与 [3H]AVP 结合后会广泛内化。约 87%的细胞表面结合的 [3H]AVP 被内化,并在与 1 nM [3H]AVP 孵育期间对酸洗脱具有抗性。相比之下,在表达 V1A 受体的细胞中,较少的配体(35%)被内化。细胞骨架蛋白抑制剂、β-arrestin 2 的 siRNA 或从细胞外缓冲液中去除氯化钠可部分减轻 V1B 受体的广泛内化,表明这种内化涉及网格蛋白包被的凹陷。总之,这些结果表明,调节质膜中 V1B 受体数量和亲和力的机制与 V1A 和 V2 受体的相应机制明显不同,并在应激条件下(即血管加压素释放增加时)发挥关键作用。

相似文献

1
Subcellular localization and internalization of the vasopressin V1B receptor.血管加压素 V1B 受体的亚细胞定位和内化。
Eur J Pharmacol. 2015 Oct 15;765:291-9. doi: 10.1016/j.ejphar.2015.08.043. Epub 2015 Aug 28.
2
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.[1-脱氨基-4-环己基丙氨酸]精氨酸加压素:一种强效且特异性的血管加压素V1b受体激动剂。
Endocrinology. 2002 Dec;143(12):4655-64. doi: 10.1210/en.2002-220363.
3
Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.血管加压素通过V1b受体刺激胰岛细胞释放胰岛素:药理学与基因敲除相结合的研究方法
Mol Pharmacol. 2004 Mar;65(3):623-9. doi: 10.1124/mol.65.3.623.
4
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.强效非肽类人血管加压素V1A和V2受体拮抗剂YM087的药理学特性
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63-9. doi: 10.1007/pl00005139.
5
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.大鼠血管加压素V(1b)受体首个选择性激动剂的设计与合成:基于脱氨基-[半胱氨酸1]精氨酸血管加压素4位和8位的修饰
J Med Chem. 2007 Feb 22;50(4):835-47. doi: 10.1021/jm060928n.
6
Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors.精氨酸加压素与V1a和V1b加压素受体结合位点的定位
Mol Endocrinol. 2007 Feb;21(2):512-23. doi: 10.1210/me.2006-0202. Epub 2006 Nov 2.
7
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.编码人血管升压素V1a受体的cDNA的分子克隆、测序及功能表达
J Biol Chem. 1994 Feb 4;269(5):3304-10.
8
The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.血管加压素对幼鼠舌下神经和面运动神经元的兴奋作用是由V1a而非V1b受体介导的,且与细胞内钙信号传导无关。
Eur J Neurosci. 2006 Sep;24(6):1565-74. doi: 10.1111/j.1460-9568.2006.05038.x.
9
Extrapituitary expression of the rat V1b vasopressin receptor gene.大鼠V1b血管加压素受体基因的垂体外表达。
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6783-7. doi: 10.1073/pnas.92.15.6783.
10
Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors.血管加压素V1b受体激动剂结合与内化过程中的联合钠离子敏感性
Sci Rep. 2016 May 3;6:25327. doi: 10.1038/srep25327.

引用本文的文献

1
Agonist dependency of the second phase access of β-arrestin 2 to the heteromeric µ-V1b receptor.β-arrestin 2 与异源 µ-V1b 受体第二阶段进入的激动剂依赖性。
Sci Rep. 2021 Aug 4;11(1):15813. doi: 10.1038/s41598-021-94894-y.
2
The Biology of Vasopressin.血管加压素的生物学
Biomedicines. 2021 Jan 18;9(1):89. doi: 10.3390/biomedicines9010089.
3
Vasopressin and v1br gene expression is increased in the hypothalamic pvn of borderline hypertensive rats.加压素和 v1br 基因在边缘型高血压大鼠下丘脑室旁核中的表达增加。
Hypertens Res. 2020 Nov;43(11):1165-1174. doi: 10.1038/s41440-020-0469-2. Epub 2020 May 15.
4
Translational assessment of a genetic engineering methodology to improve islet function for transplantation.用于改善移植胰岛功能的基因工程方法的转化评估。
EBioMedicine. 2019 Jul;45:529-541. doi: 10.1016/j.ebiom.2019.06.045. Epub 2019 Jun 29.
5
Vasopressin Increases Urinary Acidification V1a Receptors in Collecting Duct Intercalated Cells.加压素增加集合管闰细胞中的尿酸化 V1a 受体。
J Am Soc Nephrol. 2019 Jun;30(6):946-961. doi: 10.1681/ASN.2018080816. Epub 2019 May 16.
6
Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors.血管加压素V1b受体激动剂结合与内化过程中的联合钠离子敏感性
Sci Rep. 2016 May 3;6:25327. doi: 10.1038/srep25327.